MedTrace Logo

Evaluating Benefits of Hearing Aid Microphone Directionality Technologies

NCT04953390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2022-11-09

Study results available
· View outcomes & findings →

Summary

This study will evaluate the impact of hearing aid microphone directionality technologies and settings on speech understanding in noise for experienced hearing aid users. It will also evaluate the participant's spatial awareness of sounds using these different hearing aid microphone directionality technologies.

Conditions

Interventions

DEVICE

Phonak Audeo hearing aid

Commercially available hearing aid with three different microphone settings: DIR1, DIR2, and DIR3

DEVICE

Phonak hearing aid with multiple directionality settings, adjustable via a mobile app

Commercially available hearing aid with multiple directionality settings which will be adjustable by user via a mobile app during a home trial period.

Sponsors & Collaborators

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Kevin Seitz-Paquette, AuD · Sonova AG

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-03
Primary Completion
2021-07-02
Completion
2021-07-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953390 on ClinicalTrials.gov